시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
유전자 독성 검사 시장 규모, 점유율, 성장 분석 : 검사 방법별, 제품별, 어세이 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Genetic Toxicology Testing Market Size, Share, and Growth Analysis, By Testing Methodology (In Vitro Testing, In Vivo Testing), By Product (Reagents & Consumables, Assay Kits), By Assay Type, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1663118
리서치사 : SkyQuest
발행일 : 2025년 02월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,590,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,879,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,168,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

유전자 독성 검사 시장 규모는 2023년에 15억 8,000만 달러로 평가되며, 2024년 17억 7,000만 달러에서 2032년에는 43억 1,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 11.8%로 성장할 전망입니다.

유전자 독성 테스트 시장은 제약, 생명공학, 화학 분야에서 신약, 화학물질, 소비자 제품의 종합적인 안전성 평가를 보장하기 위해 점점 더 중요해지고 있습니다. 규제 당국의 요구 사항 증가, 시험 방법의 발전, 건강과 안전에 대한 사회적 관심 증가로 인해 이 시장은 크게 성장하고 있습니다. 주요 성장 촉진요인으로는 의약품 및 화학물질에 대한 연구개발 활동 증가, 전 세계 보건 당국의 엄격한 규제, 유전독성 물질과 관련된 장기적 위험에 대한 인식 증가 등을 들 수 있습니다. Ames 시험과 같은 전통적인 방법이 여전히 중요하지만, in vitro 소핵 시험이나 하이스루풋 스크리닝과 같은 혁신적 기술로 강화되고 있습니다. 이러한 비동물 시험 모델로의 진화는 윤리적 기준에 부합하며, 시장 성장을 가속하고 이 분야를 전문으로 하는 주요 기업 및 위탁 연구 기관의 서비스 제공의 폭을 넓혀주고 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

유전자 독성 검사 시장 규모 : 검사 방법별 & CAGR(2025-2032)

유전자 독성 검사 시장 규모 : 제품별 & CAGR(2025-2032)

유전자 독성 검사 시장 규모 : 어세이 유형별 & CAGR(2025-2032)

유전자 독성 검사 시장 규모 : 최종사용자별 & CAGR(2025-2032)

유전자 독성 검사 시장 규모 : 지역별 & CAGR(2025-2032)

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Genetic Toxicology Testing Market size was valued at USD 1.58 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 4.31 billion by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032).

The genetic toxicology testing market is increasingly pivotal in the pharmaceutical, biotechnology, and chemical sectors, ensuring comprehensive safety assessments of new drugs, chemicals, and consumer products. With rising regulatory demands, advancements in testing methodologies, and a growing public focus on health and safety, this market is witnessing significant expansion. Key growth drivers include intensified research and development activities in pharmaceuticals and chemicals, strict regulations from global health authorities, and rising awareness of the long-term risks associated with genotoxic substances. While traditional methods like the Ames test remain vital, they are being enhanced by innovative techniques such as in vitro micronucleus assays and high-throughput screening. This evolution towards non-animal testing models is in line with ethical standards, facilitating market growth and broadening the service offerings of key players and contract research organizations specializing in this field.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genetic Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genetic Toxicology Testing Market Segments Analysis

Global Genetic Toxicology Testing Market is segmented by Testing Methodology, Product, Assay Type, End User and region. Based on Testing Methodology, the market is segmented into In Vitro Testing, In Vivo Testing, Computational Toxicology and High-Throughput Screening. Based on Product, the market is segmented into Reagents & Consumables, Assay Kits and Services. Based on Assay Type, the market is segmented into Ames Test, Micronucleus Test, Comet Assay and Chromosomal Aberration Test. Based on End User, the market is segmented into Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs) and Government Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genetic Toxicology Testing Market

A key factor propelling the growth of the Genetic Toxicology Testing market is the increasing awareness among both individuals and healthcare professionals regarding the significance of genetic health and its implications. This heightened understanding underscores the importance of genetic toxicology testing, which plays a crucial role in identifying potential risks linked to environmental exposures, including chemicals, pharmaceuticals, and pollutants. By providing insights into these risks, genetic toxicology testing facilitates personalized healthcare approaches and promotes preventive strategies, ultimately contributing to better health outcomes and enhancing public awareness of genetic considerations in health management.

Restraints in the Genetic Toxicology Testing Market

The Genetic Toxicology Testing market faces significant restraints due to ethical concerns associated with the analysis of genetic information. Issues surrounding privacy, informed consent, and the potential for misuse of personal data present major challenges. The meticulous collection, storage, and application of genetic data necessitate compliance with stringent privacy regulations, which can serve as a barrier to the broad acceptance and implementation of this testing in various sectors. Consequently, these ethical and regulatory dilemmas may impede the growth of the market, limiting its potential benefits and prompting cautious engagement from both providers and consumers.

Market Trends of the Genetic Toxicology Testing Market

The genetic toxicology testing market is experiencing a pronounced trend towards in vitro testing methods, reflecting a broader shift in regulatory and scientific practices. Traditional animal models are progressively being supplanted by cell-based assays that not only alleviate ethical concerns but also enhance the speed and cost-efficiency of testing processes. Prominent in this transition are in vitro techniques such as the Ames test, micronucleus assay, and Comet assay, which demonstrate a strong correlation with human biology and offer reliable assessments of genotoxicity and mutagenicity. This trend is further reinforced by the endorsement from regulatory agencies advocating for more humane and efficient testing methodologies, propelling the accelerated adoption of these innovative approaches across the industry.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Genetic Toxicology Testing Market Size by Testing Methodology & CAGR (2025-2032)

Global Genetic Toxicology Testing Market Size by Product & CAGR (2025-2032)

Global Genetic Toxicology Testing Market Size by Assay Type & CAGR (2025-2032)

Global Genetic Toxicology Testing Market Size by End User & CAGR (2025-2032)

Global Genetic Toxicology Testing Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기